Zhirui Zeng

20PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 27, 2026
TRIM27-Cas9-loaded EVs suppress HCC proliferation and enhance responsiveness to anti-PD-1 therapy by promoting ACSL4-mediated ferroptosis.

|Apr 16, 2026
m1A-mediated regulation of BIRC2 mRNA stability drives apoptosis evasion and tumor progression in liver cancer.

|Feb 16, 2026
CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy.

Chujiao Hu, Huading Tai, Renguang Zhu

|Apr 09, 2025
Bioinformatics Combined With Biological Experiments to Identify the Pathogenetic Link of Type 2 Diabetes for Breast Cancer.

Xin Bao, Zhirui Zeng, Wenjing Tang

|Aug 28, 2024
Identification of Clinical Value and Biological Effects of XIRP2 Mutation in Hepatocellular Carcinoma.

Dahuan Li, Xin Bao, Shan Lei

|May 22, 2024
Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.

Feng Pan, Runsang Pan, Rui Hu

Pageof 4

Frequent Collaborators

8 joint publications

Shan Lei

4 joint publications

Wenpeng Cao

3 joint publications

Tengxiang Chen

2 joint publications

Zhangxia Ren